Opinion on  Applera Corp. Celera Group (CRA)     Sector: Services  >  Industry: Business Services
Applera Corp. Celera Group

Celera Group, a molecular diagnostics business, engages in the identification and validation of diagnostic markers using proprietary genomics and proteomics discovery platforms. The company, through its strategic alliance with Abbott Laboratories, discovers, develops, and commercializes in vitro diagnostic products for disease detection, prediction of disease predisposition, disease progression monitoring, and therapy selection. It manufactures five product groups, including ViroSeq HIV-1 Genotyping System, an aid to physicians in monitoring and treating HIV-1 infection; products that are used for the detection of mutations in the cystic fibrosis transmembrane conductance regulator gene, which cause cystic fibrosis; hepatitis C virus analyte specific reagents (ASRs); ASRs for the detection of mutations in the FMR-1 gene, which cause Fragile X Syndrome; and ASRs for the detection of mutations in genes known to be involved in deep vein thrombosis. In addition, Celera Group performs contract manufacturing and technology development services for appropriately licensed clinical laboratories for the development and manufacture of reagents for use by the clinical laboratories in the performance of clinical testing services. Further, it is conducting genomics research programs in various areas, including Alzheimer’s disease; autoimmune and inflammatory diseases; breast cancer; cardiovascular diseases; and liver diseases. Celera Group has collaborations with Abbott Laboratories; Genentech, Inc.; Medarex, Inc.; Seattle Genetics, Inc.; and General Electric Company, as well as research collaboration with Ipsen S.A. to develop biomarker and pharmacogenomic tests for growth failure patients. The company was founded in 1937. It was formerly known as Celera Genomics Group and changed its name to Celera Group in 2006. Celera Group is headquartered in Alameda, California. Celera Group is a part of Applera Corporation.